Rigel Pharmaceuticals Raises FY2026 Sales Guidance from $285.000M-$295.000M to $290.000M-$295.000M vs $305.733M Est
Benzinga Newsdesk 21 hours ago
NewsGuidance
Rigel Pharmaceuticals (NASDAQ:RIGL) raises FY2026 sales outlook from $285.000 million-$295.000 million to $290.000 million-$295.000 million vs $305.733 million estimate.
Rigel Pharmaceuticals (NASDAQ:RIGL) raises FY2026 sales outlook from $285.000 million-$295.000 million to $290.000 million-$295.000 million vs $305.733 million estimate.